OGEN (Oragenics Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by OGEN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | John Spencer | Chief Financial Officer | A | — | — |
| 2026-01-22 | Fred Telling | Director | Sell | — | — |
| 2025-12-15 | ALAN W DUNTON | Director | A | — | — |
| 2025-12-15 | CHARLES L POPE | Director | A | — | — |
| 2025-12-15 | ROBERT C KOSKI | Director | A | — | — |
| 2025-12-15 | Janet Huffman | CEO and CFO | A | — | — |
| 2025-12-15 | Natasha Giordano | Director | A | — | — |
| 2025-12-15 | JOHN P GANDOLFO | Director | A | — | — |
| 2025-12-15 | Fred Telling | Director | Sell | — | — |
| 2025-06-18 | Odyssey Health, Inc. | 10%+ Owner | Sell | — | — |
| 2025-06-16 | Odyssey Health, Inc. | 10%+ Owner | Sell | — | — |
| 2024-12-13 | ROBERT C KOSKI | Director | C | — | — |
| 2024-12-09 | ALAN W DUNTON | Director | Sell | — | — |
| 2024-12-09 | Fred Telling | Director | Sell | — | — |
| 2024-09-20 | ALAN W DUNTON | Director | A | — | — |
| 2024-09-20 | JOHN P GANDOLFO | Director | A | — | — |
| 2024-09-20 | Fred Telling | Director | A | — | — |
| 2024-09-20 | Kimberly M Murphy | Director | A | — | — |
| 2024-09-20 | ROBERT C KOSKI | Director | A | — | — |
| 2024-09-20 | Bruce A. Cassidy Sr. | Director | A | — | — |
| 2024-09-20 | Janet Huffman | Chief Financial Officer | A | — | — |
| 2024-09-20 | CHARLES L POPE | Director | A | — | — |
| 2024-09-20 | J MICHAEL REDMOND | President | A | — | — |
| 2024-01-02 | J MICHAEL REDMOND | President | A | — | — |
| 2023-12-01 | Fred Telling | Director | Sell | — | — |
| 2023-10-06 | JOHN P GANDOLFO | Director | A | — | — |
| 2023-10-06 | Bruce A. Cassidy Sr. | Director | A | — | — |
| 2023-08-10 | CHARLES L POPE | Director | A | — | — |
| 2023-08-10 | ALAN W DUNTON | Director | A | — | — |
| 2023-08-10 | Janet Huffman | CFO, Secretary and Treasurer | A | — | — |
| 2023-08-10 | ROBERT C KOSKI | Director | A | — | — |
| 2023-08-10 | Fred Telling | Director | A | — | — |
| 2023-08-10 | Kimberly M Murphy | CEO and President | A | — | — |
| 2023-03-08 | Janet Huffman | CFO, Secretary and Treasurer | A | — | — |
| 2023-01-03 | ROBERT C KOSKI | Director | Sell | — | — |
| 2022-12-16 | ROBERT C KOSKI | Director | Sell | — | — |
| 2022-12-15 | ROBERT C KOSKI | Director | Sell | — | — |
| 2022-12-12 | ROBERT C KOSKI | Director | Sell | — | — |
| 2022-12-09 | ROBERT C KOSKI | Director | Sell | — | — |
| 2022-12-01 | ROBERT C KOSKI | Director | Sell | — | — |
| 2022-08-02 | Fred Telling | Director | A | — | — |
| 2022-08-02 | ROBERT C KOSKI | Director | A | — | — |
| 2022-08-02 | ALAN W DUNTON | Director | A | — | — |
| 2022-08-02 | Michael O'Keefe Sullivan | Chief Financial Officer | A | — | — |
| 2022-08-02 | CHARLES L POPE | Director | A | — | — |
| 2022-06-27 | Fred Telling | Director | A | — | — |
| 2022-06-24 | Fred Telling | Director | A | — | — |
| 2022-06-24 | Kimberly M Murphy | CEO and President | A | — | — |
| 2022-06-24 | Michael O'Keefe Sullivan | Chief Financial Officer | A | — | — |
| 2022-06-21 | Fred Telling | Director | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 5,044 | — |
| — | 10%+ Owner | 2,236 | — |
| — | Director | 1,710 | — |
| — | Director | 948 | — |
| — | Director | 854 | — |
| — | Director | 849 | — |
| — | CEO and President | 833 | — |
| — | 10%+ Owner | 805 | — |
| — | 10%+ Owner | 744 | — |
| — | 10%+ Owner | 679 | — |
| — | CEO and CFO | 500 | — |
| — | 10%+ Owner | 183 | — |
| — | Director | 84 | — |
| — | CEO and President | 37 | — |
| — | 10%+ Owner | 30 | — |
| — | President and CEO | 21 | — |
| — | Chief Financial Officer | 19 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OGEN quote page; the site-wide leaderboard is on the insider transactions hub.